ECRIN is pleased to announce that a new article has been published in The Lancet Gastroenterology & Hepatology entitled 'Safety of two different doses of simvastatin plus rifaximin in decomp
The RItrain project will be holding a workshop for the research infrastructure (RI) community from 20 to 21 November 2019 in Brussels, Belgium.
The Executive Masters in Management of Research Infrastructures (EMMRI) is now taking applications for the third edition, which will start in March 2020.
The European Joint Programme on Rare Diseases (EJP-RD) project has just launched an online Support Office.
ICPerMed has developed a vision of how the use of personalised medicine approaches will promote 'next-generation' medicine in 2030, more firmly centred on the individual’s personal characteristics, leading to increased effectiveness, economic value, and equitable access for all citizens to the be
A new paper has been published in the International Journal of Bipolar Disorders entitled 'Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview
Dr. Donato Bonifazi
The first EULAC-PerMed project newsletter has now been published.
ECRIN is holding its annual internal Summer School from 11 to 13 September 2019 in Balatonfüred, Hungary.
ECRIN co-organised the 'FAIR Enough' meeting in Brussels from 4 to 5 September 2019 as part of the EOSC-Life project. The goal was to align partner strategies and project initiatives regarding FAIR data and related issues.
ECRIN's Director General, Jacques Demotes, is participating in the Economic Forum in Krynica, Poland, from 3 to 5 September 2019. Poland is ECRIN's newest observer country, having joined the organisation on 23 August 2019. Learn more
The PERsonalised MedicIne Trials (‘PERMIT’) project on methodological standards for personalised medicine research has received a positive funding decision from Horizon 2020 (grant agreement number 874825).
ECRIN is pleased to announce that Poland has officially joined as an observer country. The Polish Medical Research Agency will be the national scientific partner.
The Innovative Medicines Initiative (IMI) published its July 2019 newsletter.
ECRIN is recruiting a European Correspondent for Spain, to be based in Barcelona, within ECRIN's Spanish scientific national partner, FCRB. For more information, please click here